Reported Earnings • May 14
First quarter 2026 earnings released: EPS: US$0.18 (vs US$0.22 in 1Q 2025) First quarter 2026 results: EPS: US$0.18 (down from US$0.22 in 1Q 2025). Revenue: US$25.3m (up 59% from 1Q 2025). Net income: US$1.72m (down 15% from 1Q 2025). Profit margin: 6.8% (down from 13% in 1Q 2025). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 06
FitLife Brands, Inc. to Report Q1, 2026 Results on May 14, 2026 FitLife Brands, Inc. announced that they will report Q1, 2026 results on May 14, 2026 Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 31% After last week's 31% share price decline to US$9.80, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 17x in the Personal Products industry in the US. Total returns to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$13.37 per share. Buy Or Sell Opportunity • Apr 06
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 34% to US$10.61. The fair value is estimated to be US$13.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 38% in 2 years. Earnings are forecast to grow by 77% in the next 2 years. New Risk • Apr 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$99.6m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.8% net profit margin). Market cap is less than US$100m (US$99.6m market cap). Reported Earnings • Apr 01
Full year 2025 earnings released: EPS: US$0.68 (vs US$0.98 in FY 2024) Full year 2025 results: EPS: US$0.68 (down from US$0.98 in FY 2024). Revenue: US$81.5m (up 26% from FY 2024). Net income: US$6.33m (down 30% from FY 2024). Profit margin: 7.8% (down from 14% in FY 2024). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Mar 30
FitLife Brands, Inc. to Report Q4, 2025 Results on Mar 31, 2026 FitLife Brands, Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026 New Risk • Nov 14
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. This is currently the only risk that has been identified for the company. Tillkännagivande • Nov 08
FitLife Brands, Inc. to Report Q3, 2025 Results on Nov 13, 2025 FitLife Brands, Inc. announced that they will report Q3, 2025 results on Nov 13, 2025 Reported Earnings • Aug 14
Second quarter 2025 earnings released: EPS: US$0.19 (vs US$0.29 in 2Q 2024) Second quarter 2025 results: EPS: US$0.19 (down from US$0.29 in 2Q 2024). Revenue: US$16.1m (down 4.7% from 2Q 2024). Net income: US$1.75m (down 34% from 2Q 2024). Profit margin: 11% (down from 16% in 2Q 2024). Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 27% per year. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$15.45, the stock trades at a trailing P/E ratio of 16.4x. Average forward P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 109% over the past three years. Tillkännagivande • Aug 01
FitLife Brands, Inc. to Report Q2, 2025 Results on Aug 14, 2025 FitLife Brands, Inc. announced that they will report Q2, 2025 results on Aug 14, 2025 Tillkännagivande • Jun 25
FitLife Brands, Inc., Annual General Meeting, Aug 12, 2025 FitLife Brands, Inc., Annual General Meeting, Aug 12, 2025. Location: 5214 s 136th street, nebraska, omaha United States Reported Earnings • May 15
First quarter 2025 earnings released: EPS: US$0.22 (vs US$0.23 in 1Q 2024) First quarter 2025 results: EPS: US$0.22 (down from US$0.23 in 1Q 2024). Revenue: US$15.9m (down 3.7% from 1Q 2024). Net income: US$2.02m (down 6.6% from 1Q 2024). Profit margin: 13% (in line with 1Q 2024). Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 06
FitLife Brands, Inc. to Report Q1, 2025 Results on May 15, 2025 FitLife Brands, Inc. announced that they will report Q1, 2025 results on May 15, 2025 Tillkännagivande • Apr 28
FitLife Brands, Inc. Announces Board and Committee Changes FitLife Brands, Inc. announced the resignation of Todd Ordal as a member of the Company’s Board of Directors. Mr. Ordal’s resignation, effective on April 25, 2025, was part of the Company’s ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company’s management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of the Company appointed Shannon Pappas as an independent director to fill the vacancy resulting from Mr. Ordal’s resignation. The Board also appointed Ms. Pappas to serve as a member of the Audit, Compensation, and Nominating/Corporate Governance Committees. Ms. Pappas has over 25 years of experience in beauty, skincare, health, fitness, and consumer goods, with functional expertise in strategic growth, digital commerce, financial management, and market expansion for both public and private companies. Most recently, Ms. Pappas served as Consumer President & Head of Digital Commerce at Beauty Industry Group, a global hair extensions and beauty company. Prior to that, as President and General Manager of The Proactiv Company, a skincare brand, she managed commercial operations, finance, and market expansion. Ms. Pappas led the sale of The Proactiv Company and its integration into Taro Pharmaceuticals. Ms. Pappas also has management experience in the fitness industry, first at Beachbody LLC, and at the International Sports Sciences Association, where she achieved revenue growth through strategic digital marketing, lead optimization, and an expanded brand presence. Ms. Pappas also worked in strategy roles at The Wonderful Company and Boston Consulting Group, focusing on corporate growth and post-merger integration. Ms. Pappas holds an M.B.A. from Northwestern University’s Kellogg School of Management and a Bachelor of Science in Exercise and Sports Science from the University of Arizona, where she was a Division I athlete, varsity soccer captain, and varsity women’s basketball competitor. New Risk • Apr 06
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$95.9m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to US$10.40, the stock trades at a trailing P/E ratio of 10.7x. Average forward P/E is 16x in the Personal Products industry in the US. Total returns to shareholders of 98% over the past three years. Reported Earnings • Mar 27
Full year 2024 earnings released: EPS: US$0.98 (vs US$0.59 in FY 2023) Full year 2024 results: EPS: US$0.98 (up from US$0.59 in FY 2023). Revenue: US$64.5m (up 22% from FY 2023). Net income: US$8.98m (up 70% from FY 2023). Profit margin: 14% (up from 10.0% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Mar 07
FitLife Brands, Inc. to Report Q4, 2024 Results on Mar 27, 2025 FitLife Brands, Inc. announced that they will report Q4, 2024 results After-Market on Mar 27, 2025 Reported Earnings • Nov 17
Third quarter 2024 earnings released: EPS: US$0.46 (vs US$0.38 in 3Q 2023) Third quarter 2024 results: EPS: US$0.46 (up from US$0.38 in 3Q 2023). Revenue: US$16.0m (up 15% from 3Q 2023). Net income: US$2.13m (up 25% from 3Q 2023). Profit margin: 13% (up from 12% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Nov 07
FitLife Brands, Inc. to Report Q3, 2024 Results on Nov 14, 2024 FitLife Brands, Inc. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024 Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: US$0.57 (vs US$0.44 in 2Q 2023) Second quarter 2024 results: EPS: US$0.57 (up from US$0.44 in 2Q 2023). Revenue: US$16.9m (up 15% from 2Q 2023). Net income: US$2.63m (up 34% from 2Q 2023). Profit margin: 16% (up from 13% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings. Tillkännagivande • Aug 15
Fitlife Brands, Inc. Appoints Matt Lingenbrink as Member of Board of Directors FitLife Brands, Inc. in its annual general meeting held on August 13, 2024 elected Matt Lingenbrink to serve as a member of the Board of Directors of the Company until the Company’s next annual meeting of stockholders or until his successor is duly elected and qualified. Matt Lingenbrink, 42, currently leads the marketing organization of Interstate Batteries as Vice President, Marketing and E-commerce since April 2024. Prior to his time at Interstate Batteries, he held various roles leading corporate strategy, business development, and route-to-market at Keurig Dr Pepper Inc., and its predecessor Dr Pepper Snapple Group, from August 2017 to April 2024. Prior to that, Mr. Lingenbrink worked with Bain & Company from September 2007 to August 2017, consulting with large clients across the consumer packaged goods industry and other industries on growth strategy, corporate diligence, and post-merger integration. Mr. Lingenbrink received his Bachelor’s Degree and a Master’s Degree in Accounting from Brigham Young University, and earned an M.B.A. from Harvard Business School. Tillkännagivande • Aug 06
FitLife Brands, Inc. to Report Q2, 2024 Results on Aug 14, 2024 FitLife Brands, Inc. announced that they will report Q2, 2024 results After-Market on Aug 14, 2024 Tillkännagivande • Jul 08
FitLife Brands, Inc., Annual General Meeting, Aug 13, 2024 FitLife Brands, Inc., Annual General Meeting, Aug 13, 2024. Location: 5214 s. 136th street, omaha, nebraska United States Tillkännagivande • Jul 07
FitLife Brands, Inc Announces Retirement of Lew Jaffe as Director FitLife Brands, Inc. announced that Lew Jaffe, who has served as a director of FitLife and its predecessor entities since 2010, will retire from the Board and not stand for re-election at the Company’s 2024 annual meeting of stockholders. The Board plans to nominate a new director in its proxy statement, which is anticipated to be filed with the SEC on July 5, 2024. Mr. Jaffe indicated that his decision not to stand for re-election was not the result of any disagreement with the Company’s management or Board of Directors. In accordance with good corporate governance practices, the Board of Directors intends to regularly evaluate Board constitution and anticipates additional changes over the next couple of years. New Risk • Jul 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (50% accrual ratio). Minor Risks High level of debt (47% net debt to equity). Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Significant insider selling over the past 3 months (US$335k sold). Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to US$33.50, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 22x in the Personal Products industry in the US. Total returns to shareholders of 244% over the past three years. Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to US$27.93, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 23x in the Personal Products industry in the US. Total returns to shareholders of 198% over the past three years. Recent Insider Transactions • Jun 06
Chief Retail Officer recently sold US$335k worth of stock On the 3rd of June, Patrick Ryan sold around 11k shares on-market at roughly US$31.80 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$433k more than they bought in the last 12 months. Reported Earnings • May 16
First quarter 2024 earnings released: EPS: US$0.47 (vs US$0.035 in 1Q 2023) First quarter 2024 results: EPS: US$0.47 (up from US$0.035 in 1Q 2023). Revenue: US$16.5m (up 54% from 1Q 2023). Net income: US$2.16m (up US$2.00m from 1Q 2023). Profit margin: 13% (up from 1.5% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings. Tillkännagivande • May 10
FitLife Brands, Inc. to Report Q1, 2024 Results on May 14, 2024 FitLife Brands, Inc. announced that they will report Q1, 2024 results on May 14, 2024 Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to US$27.77, the stock trades at a trailing P/E ratio of 24.1x. Average trailing P/E is 26x in the Personal Products industry in the US. Total returns to shareholders of 247% over the past three years. Reported Earnings • Mar 31
Full year 2023 earnings released: EPS: US$1.18 (vs US$0.97 in FY 2022) Full year 2023 results: EPS: US$1.18 (up from US$0.97 in FY 2022). Revenue: US$52.7m (up 83% from FY 2022). Net income: US$5.30m (up 20% from FY 2022). Profit margin: 10.0% (down from 15% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings. New Risk • Mar 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (24% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (9.6% net profit margin). Shareholders have been diluted in the past year (3.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$98k sold). Recent Insider Transactions • Dec 20
Insider recently sold US$98k worth of stock On the 15th of December, Patrick Ryan sold around 4k shares on-market at roughly US$24.50 per share. This transaction amounted to 28% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$81k more than they bought in the last 12 months. New Risk • Nov 15
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (24% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (9.6% net profit margin). Market cap is less than US$100m (US$88.9m market cap). Tillkännagivande • Sep 29
FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million. FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to US$18.85, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 24x in the Personal Products industry in the US. Total returns to shareholders of 411% over the past three years. Board Change • Sep 19
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 4 highly experienced directors. Chairman & CEO Dayton Judd was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jul 01
FitLife Brands, Inc., Annual General Meeting, Aug 09, 2023 FitLife Brands, Inc., Annual General Meeting, Aug 09, 2023, at 09:00 Central Daylight. Location: 5214 S. 136th Street, Omaha, Nebraska Omaha United States Agenda: To elect five directors to our Board of Directors, each to serve until company's next Annual Meeting of Stockholders or until his respective successor is elected and qualified; to approve, on an advisory basis, the compensation of our Named Executive Officers; to ratify the appointment of Weinberg & Company, P.A. as our independent auditors for the fiscal year ending December 31, 2023; and to consider other matters. 
